Does Cymbalta (duloxetine) cause hot flashes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Cymbalta (Duloxetine) Cause Hot Flashes?

No, Cymbalta (duloxetine) does not cause hot flashes—in fact, it is used to treat them. Duloxetine is an SNRI (serotonin-norepinephrine reuptake inhibitor) that has demonstrated efficacy in reducing hot flashes, particularly in breast cancer survivors and menopausal women who cannot or choose not to take hormone therapy.

Evidence for Duloxetine Treating Hot Flashes

Duloxetine is recognized as an effective non-hormonal treatment option for moderate to severe vasomotor symptoms (hot flashes). Clinical practice guidelines specifically recommend SSRIs/SNRIs, including duloxetine, for women seeking pharmacological management of hot flashes when hormone therapy is contraindicated or declined 1. Studies in breast cancer survivors have shown that SNRIs like venlafaxine and desvenlafaxine (closely related to duloxetine) significantly reduce hot flash frequency and severity 2.

A comparative study directly evaluated duloxetine versus escitalopram for hot flashes in breast cancer survivors and found that both drugs showed significant reduction in hot flash frequency and severity after 12 weeks of treatment, with no significant difference between the two agents 3. This confirms duloxetine's therapeutic role rather than a causative role in hot flashes.

The Paradox: Flushing as a Side Effect

Here's the important nuance: While duloxetine treats hot flashes, it can cause facial flushing as a distinct adverse effect. The FDA drug label lists "flushing" as an adverse reaction occurring in 2-3% of patients 4. This flushing is different from menopausal hot flashes:

  • Facial flushing from duloxetine typically involves visible redness of the face and may be related to its effects on blood vessels
  • Menopausal hot flashes are systemic vasomotor symptoms involving warmth spreading from head to feet, followed by sweating and chills

A case report documented facial flushing in a patient taking duloxetine (though this involved inappropriate administration by opening capsules) 5. The flushing resolved after discontinuation, confirming it was drug-related.

Common Duloxetine Side Effects to Monitor

The most common adverse effects of duloxetine that occur in ≥5% of patients include 4:

  • Hyperhidrosis (excessive sweating): 6% - This is the most relevant autonomic side effect
  • Nausea: 24%
  • Dry mouth: 13%
  • Fatigue: 10%
  • Somnolence: 10%
  • Dizziness: 10%

Excessive sweating (hyperhidrosis) is notably more common than flushing and may be confused with hot flashes by patients. One case report described excessive sweating when duloxetine was combined with agomelatine 6.

Clinical Recommendations

If a patient reports "hot flashes" while on duloxetine:

  1. Clarify the symptom: Distinguish between true vasomotor hot flashes (systemic warmth, sweating, chills) versus facial flushing (localized redness) versus hyperhidrosis (excessive sweating without warmth)

  2. Consider the indication: If duloxetine was prescribed for hot flashes and symptoms persist, this represents treatment failure, not a drug side effect

  3. Evaluate timing: Drug-induced flushing typically occurs 1-2 hours post-dose 5, while menopausal hot flashes occur unpredictably

  4. Monitor blood pressure: Duloxetine can cause sustained increases in blood pressure (mean increases of 0.5 mmHg systolic, 0.8 mmHg diastolic), which should be measured before and during treatment 4

Bottom Line

Duloxetine is a treatment for hot flashes, not a cause. It may cause facial flushing or excessive sweating as distinct side effects in a small percentage of patients, but these should not be confused with the vasomotor hot flashes it is designed to treat. The evidence strongly supports its use as a non-hormonal alternative for managing menopausal vasomotor symptoms 2, 1, 3, 7.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.